Literature DB >> 5951957

The relation between lymphosarcoma and leukemia.

J W Ibbott, D M Whitelaw.   

Abstract

Of 283 cases of lymphocytic disease, 81% fell within three distinct categories: lymphocytic and lymphoblastic lymphosarcoma and lymphocytic leukemia. The remaining 19% showed transitions from more mature to less mature cell types or from local to general anatomic distribution. The clinical course was related to the cell type and the extent of disease rather than to the presence of blood stream invasion. Survival of patients with lymphocytic leukemia and of those with lymphocytic lymphosarcoma was the same, while that of patients with lymphoblastic lymphosarcoma was much shorter. Survival curves are simple exponentials and do not suggest two populations, one with disease less malignant than the other.

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 5951957      PMCID: PMC1936536     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  4 in total

1.  Calculation of survival rates for cancer.

Authors:  J BERKSON; R P GAGE
Journal:  Proc Staff Meet Mayo Clin       Date:  1950-05-24

2.  THE GENETIC NEOPLASTIC RELATIONSHIPS OF HODGKIN'S DISEASE, ALEUKAEMIC AND LEUKAEMIC LYMPHOBLASTOMA, AND MYCOSIS FUNGOIDES.

Authors:  A S Warthin
Journal:  Ann Surg       Date:  1931-01       Impact factor: 12.969

3.  Malignant Lymphoma: A Clinico-Pathologic Survey of 618 Cases.

Authors:  E A Gall; T B Mallory
Journal:  Am J Pathol       Date:  1942-05       Impact factor: 4.307

4.  Tumors and Tumor-like Conditions of the Lymphocyte, the Myelocyte, the Erythrocyte and the Reticulum Cell.

Authors:  G R Callender
Journal:  Am J Pathol       Date:  1934-07       Impact factor: 4.307

  4 in total
  1 in total

1.  The influence of chemotherapy on the management of non-Hodgkin's lymphomata at the Princess Margaret Hospital. A comparison of the results from 1962-64 with 1967-69.

Authors:  D E Bergsagel; T C Brown; J Reid
Journal:  Br J Cancer Suppl       Date:  1975-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.